Vitamin K in Parenteral Nutrition

Gastroenterology

Volumn 137, Issue 5 SUPPL, 2009, Pages

  Shearer, Martin J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENAQUINONE; PHYTOMENADIONE; WARFARIN;

ANAPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CLOTTING TEST; HEMOSTASIS; HUMAN; INTESTINE ABSORPTION; KIDNEY FAILURE; LIVER DISEASE; MALABSORPTION; PARENTERAL NUTRITION; PRIORITY JOURNAL; RISK FACTOR; THROMBOEMBOLISM; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN K DEFICIENCY; VITAMIN K METABOLISM;

EID: 71149114053     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.08.046     Document Type: Article

References (89)

1. Newman P., and Shearer M.J. Vitamin K metabolism. In: Quinn P.J., and Kagan V.E. (Eds). Subcellular biochemistry. Vol. 30: Fat-soluble vitamins (1998), Plenum Press, New York 455-488
2. Collins M.D., and Jones D. Distribution of isoprenoid quinone structural types in bacteria and their taxonomic implications. Microbiol Rev 45 (1981) 316-354
3. Suttie J.W. The importance of menaquinones in human nutrition. Annu Rev Nutr 15 (1995) 399-417
4. Stenflo J. From γ-carboxy-glutamate to protein C. J Thromb Haemost 4 (2006) 2521-2526
5. Dutt T., and Toh C.H. The Yin-Yang of thrombin and activated protein C. Br J Haematol 140 (2008) 505-515
6. Vermeer C., Shearer M.J., Zittermann A., et al. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 43 (2004) 325-335
7. Berkner K.L., and Runge K.W. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost 2 (2004) 2118-2132
8. Coutu D.L., Wu J.H., Monette A., et al. Periostin, a member of a novel family of vitamin K-dependent proteins, is expressed by mesenchymal stromal cells. J Biol Chem 283 (2008) 17991-18001
9. Luo G., Ducy P., McKee M.D., et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 (1997) 78-81
10. Murshed M., Schinke T., McKee M.D., et al. Extracellular matrix mineralization is regulated locally; different roles of two Gla-containing proteins. J Cell Biol 165 (2004) 625-630
11. Shearer M.J. Role of vitamin K and Gla proteins in the pathophysiology of osteoporosis and vascular calcification. Curr Opin Clin Nutr Metab Care 3 (2000) 433-438
12. Hoang Q.Q., Sicheri F., Howard A.J., et al. Bone recognition mechanism of porcine osteocalcin from crystal structure. Nature 425 (2003) 977-980
13. Boskey A.L., Gadaleta S., Gundberg C., et al. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 23 (1998) 187-196
14. Lee N.K., Sowa H., Hinoi E., et al. Endocrine regulation of energy metabolism by the skeleton. Cell 130 (2007) 456-469
15. Shearer M.J., and Newman P. Metabolism and cell biology of vitamin K. Thromb Haemost 100 (2008) 530-547
16. Suttie J.W. Vitamin K and human nutrition. J Am Diet Assoc 92 (1992) 585-590
17. Booth S.L., and Al Rajabi A. Determinants of vitamin K status in humans. Vitam Horm 78 (2008) 1-22
18. Shearer M.J. Vitamin K deficiency bleeding (VKDB) in early infancy. Blood Rev 23 (2009) 49-59
19. O'Shaughnessy D., Allen C., Woodcock T., et al. Echis time, under-carboxylated prothrombin and vitamin K status in intensive care patients. Clin Lab Haematol 25 (2003) 397-404
20. Harrington D.J., Western H., Seton-Jones C., et al. A study of the prevalence of vitamin K deficiency in patients with cancer referred to a hospital palliative care team and its association with abnormal haemostasis. J Clin Pathol 61 (2008) 537-540
21. Usui Y., Tanimura H., Nishimura N., et al. Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr 51 (1990) 846-852
22. Widdershoven J., van Munster P., De Abreu R., et al. Four methods compared for measuring des-carboxy-prothrombin (PIVKA-II). Clin Chem 33 (1987) 2074-2078
23. Conway S.P., Wolfe S.P., Brownlee K.G., et al. Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics 115 (2005) 1325-1331
24. Motohara K., Endo F., and Matsuda I. Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns. Lancet 2 (1985) 242-244
25. Clarke P., Mitchell S.J., Wynn R., et al. Vitamin K prophylaxis for preterm infants: a randomized controlled trial of 3 regimens. Pediatrics 118 (2006) e1657-e1666
26. Topp H., Iontcheva V., and Schöch G. Renal excretion of γ-carboxyglutamic acid and metabolic rate in 3-18 year old humans. Amino Acids 14 (1998) 371-377
27. Harrington D.J., Soper R., Edwards C., et al. Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res 46 (2005) 1053-1060
28. Harrington D.J., Booth S.L., Card D.J., et al. Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr 137 (2007) 1763-1768
29. Liebman H.A., Furie B.C., Tong M.J., et al. Des-γ-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 310 (1984) 1427-1431
30. Schurgers L.J., Geleijnse J.M., Grobbee D.E., et al. Nutritional intake of vitamins K1 (phylloquinone) and K2 (menaquinone) in the Netherlands. J Nutr Environm Med 9 (1999) 115-122
31. Booth S.L., and Suttie J.W. Dietary intake and adequacy of vitamin K. J Nutr 128 (1998) 785-788
32. Thane C.W., Paul A.A., Bates C.J., et al. Intake and sources of phylloquinone (vitamin K1): variation with socio-demographic and lifestyle factors in a national sample of British elderly people. Br J Nutr 87 (2002) 605-613
33. Thane C.W., Bolton-Smith C., and Coward W.A. Comparative dietary intake and sources of phylloquinone (vitamin K1) among British adults in 1986-7 and 2000-1. Br J Nutr 96 (2006) 1105-1115
34. Shearer M.J., Bach A., and Kohlmeier M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr 126 (1996) 1181S-1186S
35. Schurgers L.J., and Vermeer C. Determination of phylloquinone and menaquinones in food. Haemostasis 30 (2000) 298-307
36. Shearer M.J. Vitamin K metabolism and nutriture. Blood Rev 6 (1992) 92-104
37. Food and Nutrition Board, Commission on Life Sciences, National Research Council. Recommended dietary allowances. 10th ed. (1989), National Academy Press, Washington, DC
38. Olson J.A. Recommended dietary intakes (RDI) of vitamin K in humans. Am J Clin Nutr 45 (1987) 687-692
39. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc (2001), National Academy Press, Washington, DC
40. Feskanich D., Weber P., Willett W.C., et al. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 69 (1999) 74-79
41. Booth S.L., Tucker K.L., Chen H., et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr 71 (2000) 1201-1208
42. Booth S.L., Broe K.E., Gagnon D.R., et al. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr 77 (2003) 512-516
43. Booth S.L., Broe K.E., Peterson J.W., et al. Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab 89 (2004) 4904-4909
44. Kalkwarf H.J., Khoury J.C., Bean J., et al. Vitamin K, bone turnover, and bone mass in girls. Am J Clin Nutr 80 (2004) 1075-1080
45. Szulc P., Chapuy M.C., Meunier P.J., et al. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone 18 (1996) 487-488
46. Vergnaud P., Garnero P., Meunier P.J., et al. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82 (1997) 719-724
47. Luukinen H., Käkönen S.M., Pettersson K., et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15 (2000) 2473-2478
48. Szulc P., Arlot M., Chapuy M.C., et al. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 9 (1994) 1591-1595
49. Knapen M.H., Nieuwenhuijzen Kruseman A.C., Wouters R.S., et al. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int 63 (1998) 375-379
50. Cockayne S., Adamson J., Lanham-New S., et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 166 (2006) 1256-1261
51. Shea M.K., and Booth S.L. Update on the role of vitamin K in skeletal health. Nutr Rev 66 (2008) 549-557
52. Liu G., and Peacock M. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int 62 (1998) 286-289
53. Kaptoge S., Dalzell N., Welch A., et al. Vitamin K and fracture risk: an effect on bone width not BMD?. J Bone Miner Res 20 (2005) 1293
54. Knapen M.H., Schurgers L.J., and Vermeer C. Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 18 (2007) 963-972
55. Alperin J.B. Coagulopathy caused by vitamin K deficiency in critically ill hospitalized patients. JAMA 258 (1987) 1916-1919
56. Shearer M.J., McBurney A., and Barkhan P. Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam Horm 32 (1974) 513-542
57. O'Brien D.P., Shearer M.J., Waldron R.P., et al. The extent of vitamin K deficiency in patients with cholestatic jaundice: a preliminary communication. J R Soc Med 87 (1994) 320-322
58. Pereira S.P., Shearer M.J., Williams R., et al. Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding. Arch Dis Child Fetal Neonatal Ed 88 (2003) F113-F118
59. Pereira S.P., Rowbotham D., Fitt S., et al. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. J Hepatol 42 (2005) 365-370
60. Singh H., and Duerksen D.R. Vitamin K and nutrition support. Nutr Clin Pract 18 (2003) 359-365
61. Duerksen D.R., and Papineau N. Is routine vitamin K supplementation required in hospitalized patients receiving parenteral nutrition?. Nutr Clin Pract 15 (2000) 81-83
62. Duerksen D.R., and Papineau N. The prevalence of coagulation abnormalities in hospitalized patients receiving lipid-based parenteral nutrition. JPEN 28 (2004) 30-33
63. Chambrier C., Leclercq M., Saudin F., et al. Is vitamin K1 supplementation necessary in long-term parenteral nutrition?. JPEN 22 (1998) 87-90
64. Postmarketing studies for approved human drug and licensed biological products: status reports. Food and Drug Administration, HHS, Final Rule. Fed Reg 65 (2000) 64607-64619
65. Drittij-Reijnders M.J., Sels J.P., Rouflart M., et al. Vitamin K status and parenteral nutrition; the effect of Intralipid on plasma vitamin K1 levels. Eur J Clin Nutr 48 (1994) 525-527
66. Helphingstine C.J., and Bistrian B.R. New Food and Drug Administration requirements for inclusion of vitamin K in adult parenteral multivitamins. JPEN 27 (2003) 220-224
67. Conly J.M., Stein K., Worobetz L., et al. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol 89 (1994) 915-923
68. Sakai M., Yoneda S., Sasaki Y., et al. Maternal total parenteral nutrition and fetal subdural hematoma. Obstet Gynecol 101 (2003) 1142-1144
69. Minami H., Furuhashi M., Minami K., et al. Fetal intraventricular bleeding possibly due to maternal vitamin K deficiency. Fetal Diagn Ther 24 (2008) 357-360
70. Van Mieghem T., van Schoubroek D., Depiere M., et al. Fetal cerebral hemorrhage caused by vitamin K deficiency after complicated bariatric surgery. Obstet Gynecol 112 (2008) 434-436
71. Menger H., Lin A.E., Toriello H.V., et al. Vitamin K deficiency embryopathy: a phenocopy of the warfarin embryopathy due to a disorder of embryonic vitamin K metabolism. Am J Med Genet 72 (1997) 129-134
72. Shearer M.J., Rahim S., Barkhan P., et al. Plasma vitamin K1 in mothers and their newborn babies. Lancet 2 (1982) 460-463
73. Pettei M.J., Israel D., and Levine J. Serum vitamin K concentration in pediatric patients receiving total parenteral nutrition. JPEN 17 (1993) 465-467
74. Kumar D., Greer F.R., Super D.M., et al. Vitamin K status of premature infants: implications for current recommendations. Pediatrics 108 (2001) 1117-1122
75. Costakos D.T., Greer F.R., Love L.A., et al. Vitamin K prophylaxis for premature infants: 1 mg versus 0.5 mg. Am J Perinatol 20 (2003) 485-490
76. Costakos D.T., and Porte M. Did "Controversies concerning vitamin K and the newborn" cover all controversies?. Pediatrics 113 (2004) 1466-1467
77. Bern M. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy. JPEN 28 (2004) 388-398
78. Duerksen D.R. Central venous thrombosis in patients receiving long-term parenteral nutrition. Appl Physiol Nutr Metab 33 (2008) 32-38
79. Rohde L.E., de Assis M.C., and Rabelo E.R. Dietary vitamin K intake and anticoagulation in elderly patients. Curr Opin Clin Nutr Metab Care 10 (2007) 1-5
80. Schurgers L.J., Shearer M.J., Hamulyák K., et al. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood 104 (2004) 2682-2689
81. Sconce E., Khan T., Mason J., et al. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 93 (2005) 872-875
82. Sconce E., Avery P., Wynne H., et al. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 109 (2007) 2419-2423
83. Rombouts E.K., Rosendaal F.R., and van der Meer F.J.M. Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost 5 (2007) 2043-2048
84. ASPEN Board of Directors and the Clinical Guidelines Task Force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN 26 (2002) 36SA-37SA
85. Bern M.M., Lokich J.J., Wallach S.R., et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112 (1990) 423-428
86. Bach A.U., Anderson S.A., Foley A.L., et al. Assessment of vitamin K status in human subjects administered "minidose" warfarin. Am J Clin Nutr 64 (1996) 894-902
87. Pereira S.P., and Williams R. Adverse events associated with vitamin K1: results of a worldwide postmarketing surveillance programme. Pharmacoepidemiol Drug Saf 7 (1998) 173-182
88. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 76. Some antiviral and antineoplastic drugs, and other pharmaceutical agents. Vitamin K Substances (2000), IARC Press, Lyon 417-486
89. Shiraki M., Shiraki Y., Aoki C., et al. Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15 (2000) 515-521